Skip to main content
. 2013 Dec 19;13:59. doi: 10.1186/1471-2482-13-59

Table 3.

Responses to neo-adjuvant chemotherapy regimens in 174 pre-mastectomy patients in Surgical Oncology Division, UCH Ibadan in 1999-2009

  Complete response Partial response Stable disease Disease progression Total (%)
AC
34 (18.8%)
29 (16.9%)
16 (9.5%)
7 (4.1%)
86 (49.3)
CAF
16 (8.8%)
11 (6.5%)
11 (6.5%)
6 (3.5%)
44 (25.3)
CMF
4 (2.3%)
5 (2.9%)
-
2 (1.2%)
11 (6.4)
Others.
9 (5.0%)
11 (6.5%)
5 (2.9%)
8 (4.6%)
33 (19.0)
Total (%) 63 (34.9%) 56 (32.8%) 32 (18.9%) 23 (13.4%) 174 (100)

A, Adriamycin; C, Cyclophosphamide; F, 5-Fluorouracil; M, Methotrexate.